B30	Rising substance use linked to STI and HCV in Thai MSM after acute HIV infection	On-demand oral abstract session	Substance abuse (including opioid use disorder)
B30	Opioid agonist treatment improves progression through each stage of the HIV cascade of care among people living with HIV who use opioids	E-poster	Substance abuse (including opioid use disorder)
B30	Depression, anxiety, and polysubstance use among persons with HIV: baseline findings from the Promoting Access to Care Engagement (PACE) trial	E-poster	Substance abuse (including opioid use disorder)
B30	Results from a randomized controlled trial of smoking cessation medications for alcohol reduction among HIV-positive heavy drinkers and daily smokers in St. Petersburg, Russia	E-poster	Substance abuse (including opioid use disorder)
B30	Anxiety and alcohol consumption in the Miami Adult Studies on HIV (MASH) cohort during the COVID-19 pandemic	E-poster	Substance abuse (including opioid use disorder)
C15	HIV pattern and cascade of care among incarcerated people in Iran: Findings of three consecutive national bio-behavioral surveillance surveys	On-demand oral abstract session	Surveillance in key population groups
C15	Evidence of disparities in achieving viral load suppression among young Black MSM	E-poster	Surveillance in key population groups
C15	Factors associated with unsuppressed viral loads among HIV positive sexually transmitted infected patients (STI) attending STI services in South Africa (2019)	E-poster	Surveillance in key population groups
C15	SARS-CoV-2 lockdown associated with expansion of HIV transmission clusters among key populations	E-poster	Surveillance in key population groups
C21	High rates of drug resistance in individuals diagnosed with HIV in tenofovir disoproxil fumarate (TDF)-based pre-exposure prophylaxis rollout programs in Kenya, Zimbabwe, Eswatini and South Africa	Oral abstract session with live Q&A	Surveillance of drug resistance in the era of PrEP